A Regulatory Move | GenomeWeb

A Regulatory Move

China is halting the use of certain genetic tests, Forbes' Shu-Ching Jean Chen reports. In what Chen calls a vaguely worded announcement, the China Food and Drug Administration says certain technologies, including prenatal genetic testing, will be subject to governmental regulation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.